Clinical trials
Completed Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 6 |
| 2006 | 3 |
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 71 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 10 |
| Amgen | 6 |
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| Amgen Research (Munich) GmbH | 3 |
| French Innovative Leukemia Organisation | 3 |
| Bristol-Myers Squibb | 2 |
| ERYtech Pharma | 2 |
| Hospices Civils de Lyon | 2 |
| Institut Paoli-Calmettes | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 71 |
| Leukemia, Myeloid, Acute | 14 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 12 |
| Leukemia | 11 |
| Recurrence | 10 |
| Burkitt Lymphoma | 9 |
| Lymphoma, Large B-Cell, Diffuse | 7 |
| Lymphoma, Non-Hodgkin | 7 |
| Neoplasms | 7 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 7 |
Trials
Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.